Related Experiment Videos
Laparoscopic pelvic lymphadenectomy--early results
B R Prasad1, N J Parr, J W Fowler
1Department of Urological Surgery, Western General Hospital, Edinburgh, UK.
British Journal of Urology
|March 1, 1994
Summary
Laparoscopic pelvic lymphadenectomy (LPL) is a valuable tool for staging genitourinary cancers. Early results show LPL can alter patient staging and guide therapy, potentially reducing morbidity.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Accurate staging is crucial for determining appropriate treatment for genitourinary malignancies.
- Pelvic lymph node status significantly impacts treatment decisions and patient prognosis.
Purpose of the Study:
- To evaluate the initial experience and early outcomes of laparoscopic pelvic lymphadenectomy (LPL).
- To assess the utility of LPL in staging genitourinary cancers.
Main Methods:
- Ten patients with genitourinary malignancy underwent LPL between May 1991 and April 1992.
- Staging involved CT scans, bone scans, and PSA levels (for prostate cancer).
- Procedures included unilateral or bilateral laparoscopic dissection, with one conversion to open surgery.
Main Results:
- LPL altered staging in three patients (one upstaged, two downstaged), impacting therapeutic decisions.
- Operative times ranged from 2 to 3 hours, with 3 to 9 lymph nodes removed (median 5).
- Two patients experienced thromboembolic complications during subsequent definitive therapy.
Conclusions:
- Laparoscopic pelvic lymphadenectomy is effective for staging genitourinary malignancies.
- LPL aids in identifying patients suitable for radical therapy and excluding those with lymph node involvement.
- This approach may reduce treatment-related morbidity.